◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › ICCC

ImmuCell Corporation (ICCC) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-09

ImmuCell Corporation (ICCC) operates in the Biotechnology industry and is headquartered in Portland, United States with about 73 employees. Its market capitalization is roughly $104 million. In the fiscal year ended 2025-12-31, ICCC reported $28M in revenue and ($1M) in net income.

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis.

Interactive charts & full statements → Open the ICCC valuation workbench →

ICCC Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-31
Total Revenue$28M$26M$18M$19M
Gross Profit$11M$8M$4M$8M
Operating Income (EBIT)$2M($2M)($6M)($2M)
Net Income($1M)($2M)($6M)($2M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ICCC Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$10M$8M$6M$6M$8M
Gross Profit$5M$3M$2M$3M$3M
Operating Income (EBIT)$2M($0M)$0M$1M$1M
Net Income$2M($3M)($0M)$0M$1M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ICCC Free Cash Flow History

ICCC Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$42M$45M$44M$45M
Total Liabilities$16M$18M$19M$14M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ICCC viewer.

Other Companies in Biotechnology

← IBTAAll stocksICCM →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.